Accueil / Communiqués / 2018 Global Campylobacter Diagnostics Market – Forecast to 2023 – ResearchAndMarkets.com

2018 Global Campylobacter Diagnostics Market – Forecast to 2023 – ResearchAndMarkets.com

Friday, November 30th 2018 at 3:33pm UTC

DUBLIN–(BUSINESS WIRE)– The “2018
Global Campylobacter Diagnostics Market Shares, Segmentation Forecasts,
Competitive Landscape, Innovative Technologies, Latest Instrumentation,
Opportunities for Suppliers”
report has been added to ResearchAndMarkets.com’s
offering.

The report presents a detailed analysis of the Campylobacter diagnostics
market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.
Current scientific views on the Campylobacter definition, epidemiology
and etiology are reviewed.

For each country, in addition to test volume and sales projections, the
report presents sales and market share estimates for major suppliers of
Campylobacter tests.

Also, the report examines the market applications of DNA Probes,
Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews
features and operating characteristics of automated analyzers; profiles
leading suppliers and recent market entrants developing innovative
technologies and products; and identifies emerging business expansion
opportunities, alternative market penetration strategies, market entry
barriers and risks, and strategic planning issues and concerns.

The report provides the 5-year test volume and sales forecasts
by country for the following market segments:

  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs

For more information about this report visit https://www.researchandmarkets.com/research/dn45pn/2018_global?w=4.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Disease Testing

Source: Research and Markets


Voir aussi

Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® Label to Include Monotherapy

Supernus Pharmaceuticals, Inc. — Friday, December 14th 2018 at 9:02pm UTC ROCKVILLE, Md., Dec. 14, …